Fairvalue-Calculator Fairvalue-Calculator
EN DE

XBiotech Inc (XBIT) Fair Value & Analysis

Healthcare · US · Market cap $71.6M

Price$2.33
Fair Value$3.84
Upside+64.8%
Quality95/100
Evidence: Low Range $2.54 – $4.81

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

XBiotech Inc (XBIT) currently trades at $2.33, while our model-based Fair Value estimate is $3.84 — implying the stock looks roughly 64.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is XBiotech Inc (XBIT) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $3.84 versus a price of $2.33 — about +65% (undervalued). Model-based estimate, not financial advice.
What is the fair value of XBIT?
Our 21-model fair value for XBiotech Inc is $3.84 (as of Jun 25, 2026), built from audited fundamentals. The current price is $2.33.
What is the quality score of XBIT?
XBiotech Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.